Csenge Advisory Group’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Csenge Advisory Group’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-18	Closed	–	–	1751
2018 Q3	$0	Buy	+18	New	+$383	﹤0.01%	1827

Other funds holding DPLO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Csenge Advisory Group's DPLO Position: Q4 2018 in Review

Csenge Advisory Group sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q4 2018, closing a stake of 18 shares.

Csenge Advisory Group first reported a position in DPLO in Q3 2018 and held it in 1 quarter. The position peaked at $0 in Q3 2018. 157 funds tracked by Wall St. Rank hold DPLO as of Q4 2018.

Csenge Advisory Group reported no remaining DIPLOMAT PHARMACY, INC. position as of Q4 2018 after selling out during the quarter.
Csenge Advisory Group sold 18 DIPLOMAT PHARMACY, INC. shares in Q4 2018.
Csenge Advisory Group first reported a position in DIPLOMAT PHARMACY, INC. in Q3 2018 and held it in 1 quarter.
Csenge Advisory Group's DIPLOMAT PHARMACY, INC. position peaked at $0 in Q3 2018.
157 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q4 2018.

Based on Csenge Advisory Group's 13F filing for Q4 2018, filed 7 Feb 2019.